Publications by authors named "Asher D Schachter"

Claim this Profile
C
CKD progression, kidney failure, and mortality among US patients with IgA nephropathy.
John J Sim, Qiaoling Chen, Nancy Cannizzaro, Ancilla W Fernandes, Cibele Pinto, Asher D Schachter

Nephrol Dial Transplant· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment Response Rates and Kidney Outcomes among Adults with Primary FSGS.
John J Sim, Mercedes A Munis, Benjamin Lewing, Qiaoling Chen, Matthew Hill, Asher D Schachter

Clin J Am Soc Nephrol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence of Adult Primary Immunoglobulin A Nephropathy among a Racially/Ethnically Diverse Population in the United States.
John J Sim, Qiaoling Chen, Nancy Cannizzaro, Simran K Bhandari, Ancilla W Fernandes, Asher D Schachter

Am J Nephrol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence and Proportion of Primary Focal Segmental Glomerulosclerosis (FSGS) among a Racially and Ethnically Diverse Adult Patient Population between 2010 and 2021.
Mercedes A Munis, Qiaoling Chen, T Matthew Hill, Min Zhuo, Asher D Schachter

Clin J Am Soc Nephrol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Minimal Change Disease and FSGS Are a Spectrum of a Single Disease within Immune-Mediated Nephrotic Syndrome.
John J Sim, William E Smoyer, Asher D Schachter

Kidney360· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety, Pharmacokinetics, and Pharmacodynamics of Subcutaneous Sibeprenlimab in Healthy Participants.
Xiaoyan Zhang, Yanlin Wang, Jill Yarbrough, Mohit Mathur, Lee Andrews, Asher D Schachter

Clin Pharmacol Drug Dev· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
How Often Do Safety Signals Occur by Chance in First-in-Human Trials?
Gemma L Clayton, Asher D Schachter, Baldur Magnusson, Yue Li, Laurence Colin

Clin Transl Sci· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advances and unmet needs in genetic, basic and clinical science in Alport syndrome: report from the 2015 International Workshop on Alport Syndrome.
Oliver Gross, Clifford E Kashtan, Michelle N Rheault, Frances Flinter, Judith Savige, Asher D Schachter

Nephrol Dial Transplant· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drug target-gene signatures that predict teratogenicity are enriched for developmentally related genes.
Asher D Schachter, Isaac S Kohane

Reprod Toxicol· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Limited sampling strategies for sirolimus after pediatric renal transplantation.
Nauzer Forbes, Asher D Schachter, Abeer Yasin, Ajay P Sharma, Guido Filler

Pediatr Transplant· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Urinary proteome profiling to search for biomarkers in steroid-resistant nephrotic syndrome.
Avram Z Traum, Asher D Schachter

Contrib Nephrol· August 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proteomic analysis in pediatric renal disease.
Avram Z Traum, Asher D Schachter

Semin Nephrol· November 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Economic evaluation of a Bayesian model to predict late-phase success of new chemical entities.
Asher D Schachter, Marco F Ramoni, Gianluca Baio, Thomas G Roberts, Stanley N Finkelstein

Value Health· October 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Paediatric drug development.
Asher D Schachter, Marco F Ramoni

Nat Rev Drug Discov· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical forecasting in drug development.
Asher D Schachter, Marco F Ramoni

Nat Rev Drug Discov· February 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Positional cloning uncovers mutations in PLCE1 responsible for a nephrotic syndrome variant that may be reversible.
Bernward Hinkes, Roger C Wiggins, Rasheed Gbadegesin, Christopher N Vlangos, Dominik Seelow, Asher D Schachter

Nat Genet· December 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sirolimus pharmacokinetics in pediatric renal transplant recipients receiving calcineurin inhibitor co-therapy.
Asher D Schachter, Mark R Benfield, Robert J Wyatt, Paul C Grimm, Robert S Fennell

Pediatr Transplant· December 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Urine proteomic profiling of pediatric nephrotic syndrome.
Mona Khurana, Avram Z Traum, Manuel Aivado, Meghan P Wells, Manuel Guerrero, Asher D Schachter

Pediatr Nephrol· September 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Computational simulation of renal biopsy accuracy in focal segmental glomerulosclerosis.
Asher D Schachter

Pediatr Nephrol· July 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SELDI-TOF MS of quadruplicate urine and serum samples to evaluate changes related to storage conditions.
Avram Z Traum, Meghan P Wells, Manuel Aivado, Towia A Libermann, Marco F Ramoni, Asher D Schachter

Proteomics· March 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chromosomes 18 and X are quantitative trait loci for nephrotic-range proteinuria in rats.
Asher D Schachter, Takaharu Ichimura, Isaac S Kohane

Pediatr Nephrol· December 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transplantation proteomics.
Avram Z Traum, Asher D Schachter

Pediatr Transplant· December 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
On the intraoperative molecular status of renal allografts after vascular reperfusion and clinical outcomes.
Yingyos Avihingsanon, Naili Ma, Martha Pavlakis, W James Chon, Marc E Uknis, Asher D Schachter

J Am Soc Nephrol· June 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The pediatric nephrotic syndrome spectrum: clinical homogeneity and molecular heterogeneity.
Asher D Schachter

Pediatr Transplant· August 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Short sirolimus half-life in pediatric renal transplant recipients on a calcineurin inhibitor-free protocol.
Asher D Schachter, K E Meyers, L D Spaneas, J A Palmer, M Salmanullah

Pediatr Transplant· April 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis